New program aims to ease tough transition for teens with Crohn's
NCT ID NCT05221281
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a support program for teens aged 16-17.5 with Crohn's disease or ulcerative colitis as they move from pediatric to adult healthcare. The program includes personalized assessments, a transition navigator, and virtual skill-building sessions. Researchers will measure how well participants function and manage their health three years later, comparing them to teens who receive standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Multimodal behavioral intervention (individualized assessment, transition navigator, virtual skills-building, and education program)
- What this could lead to
- If successful, this could establish a standard program to help teens with Crohn's disease transition more smoothly to adult care, improving their daily functioning and mental health.
- What could go wrong
- This is a relatively small, early-stage trial (90 participants) focused on a behavioral intervention, so results may not apply broadly. Participants may not fully adhere to all components, limiting effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
90 people
The number who actually took part.
- Started
-
Feb 2022
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
16 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged 16-17.5 years * Diagnosed with IBD diagnosed using standard criteria * Ability to speak/read English at a functional (Grade 8) level * Intention to reside in Canada after transfer to adult care * Ability to use a smartphone or personal computer for the virtual intervention Exclusion Criteria: * Do not speak English fluently * Intention to leave Canada after graduation from high school
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Adolescent development are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BC Children's Hospital
Vancouver, British Columbia, V6H 3N1, Canada
-
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
-
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune aging blood tests predict which older IBD patients thrive on advanced therapies?
- Ulcerative colitis drugs put under the microscope for hidden clot risk
- Can a cheap Anti-Inflammatory drug calm ulcerative colitis?
- Can early symptom relief predict who stays on IBD biologic?
- Can a liquid diet calm Crohn's in kids?
- Which IBD therapy works best for kids? researchers compare two approaches